PTGX
Protagonist Therapeutics Inc.
Latest News for PTGX
H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Protagonist Therapeutics today and set a price target of $80.00. Tsao covers the He......
In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Protagonist Therapeutics, with a price target of $80.00. A......
Barclays analyst Etzer Darout maintained a Buy rating on Protagonist Therapeutics today and set a price target of $88.00. According to TipRanks, Da......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Protagonist Therapeutics (PTGX – Research Report) an......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $85.40 | +1.4% | 907.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW